Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Mitochondrial-targeted curcuminoids: a strategy to enhance bioavailability and anticancer efficacy of curcumin.

Reddy CA, Somepalli V, Golakoti T, Kanugula AK, Karnewar S, Rajendiran K, Vasagiri N, Prabhakar S, Kuppusamy P, Kotamraju S, Kutala VK.

PLoS One. 2014 Mar 12;9(3):e89351. doi: 10.1371/journal.pone.0089351. eCollection 2014.

PMID:
24622734
[PubMed - in process]
Free PMC Article
2.

Synthesis and biological evaluation of nonaprenylsulfates.

Ravada SR, Emani L, Mallula GR, Golakoti T.

Nat Prod Commun. 2013 Nov;8(11):1595-8.

PMID:
24427950
[PubMed - indexed for MEDLINE]
3.

Digalloylresveratrol, a novel resveratrol analog inhibits the growth of human pancreatic cancer cells.

Saiko P, Graser G, Giessrigl B, Steinmann MT, Schuster H, Lackner A, Grusch M, Krupitza G, Jaeger W, Somepalli V, Golakoti T, Fritzer-Szekeres M, Szekeres T.

Invest New Drugs. 2013 Oct;31(5):1115-24. doi: 10.1007/s10637-013-0009-x. Epub 2013 Aug 14.

PMID:
23943154
[PubMed - indexed for MEDLINE]
4.

Combination effects of digalloylresveratrol with arabinofuranosylcytosine and difluorodeoxycytidine in human leukemia and pancreatic cancer cells.

Saiko P, Graser G, Madlener S, Schwarz S, Krupitza G, Jaeger W, Somepalli V, Golakoti T, Fritzer-Szekeres M, Szekeres T.

Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1190-6. doi: 10.1080/15257770.2011.596497.

PMID:
22132974
[PubMed - indexed for MEDLINE]
5.

Cellular and molecular mechanisms of anti-inflammatory effect of Aflapin: a novel Boswellia serrata extract.

Sengupta K, Kolla JN, Krishnaraju AV, Yalamanchili N, Rao CV, Golakoti T, Raychaudhuri S, Raychaudhuri SP.

Mol Cell Biochem. 2011 Aug;354(1-2):189-97. doi: 10.1007/s11010-011-0818-1. Epub 2011 Apr 11.

PMID:
21479939
[PubMed - indexed for MEDLINE]
6.

Multifactorial anticancer effects of digalloyl-resveratrol encompass apoptosis, cell-cycle arrest, and inhibition of lymphendothelial gap formation in vitro.

Madlener S, Saiko P, Vonach C, Viola K, Huttary N, Stark N, Popescu R, Gridling M, Vo NT, Herbacek I, Davidovits A, Giessrigl B, Venkateswarlu S, Geleff S, J├Ąger W, Grusch M, Kerjaschki D, Mikulits W, Golakoti T, Fritzer-Szekeres M, Szekeres T, Krupitza G.

Br J Cancer. 2010 Apr 27;102(9):1361-70. doi: 10.1038/sj.bjc.6605656.

PMID:
20424615
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Neuroprotective and antiinflammatory properties of a novel demethylated curcuminoid.

Khanna S, Park HA, Sen CK, Golakoti T, Sengupta K, Venkateswarlu S, Roy S.

Antioxid Redox Signal. 2009 Mar;11(3):449-68. doi: 10.1089/ARS.2008.2230.

PMID:
18724833
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.

Sengupta K, Alluri KV, Satish AR, Mishra S, Golakoti T, Sarma KV, Dey D, Raychaudhuri SP.

Arthritis Res Ther. 2008;10(4):R85. doi: 10.1186/ar2461. Epub 2008 Jul 30.

PMID:
18667054
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Biosynthetic characterization and chemoenzymatic assembly of the cryptophycins. Potent anticancer agents from cyanobionts.

Magarvey NA, Beck ZQ, Golakoti T, Ding Y, Huber U, Hemscheidt TK, Abelson D, Moore RE, Sherman DH.

ACS Chem Biol. 2006 Dec 15;1(12):766-79.

PMID:
17240975
[PubMed - indexed for MEDLINE]
10.

Isolation and structure determination of cryptophycins 38, 326, and 327 from the terrestrial cyanobacterium Nostoc sp. GSV 224.

Chaganty S, Golakoti T, Heltzel C, Moore RE, Yoshida WY.

J Nat Prod. 2004 Aug;67(8):1403-6.

PMID:
15332864
[PubMed - indexed for MEDLINE]
11.

A convergent approach to cryptophycin 52 analogues: synthesis and biological evaluation of a novel series of fragment a epoxides and chlorohydrins.

Al-Awar RS, Ray JE, Schultz RM, Andis SL, Kennedy JH, Moore RE, Liang J, Golakoti T, Subbaraju GV, Corbett TH.

J Med Chem. 2003 Jul 3;46(14):2985-3007.

PMID:
12825938
[PubMed - indexed for MEDLINE]
12.

Biosynthesis of 4-methylproline in cyanobacteria: cloning of nosE and nosF genes and biochemical characterization of the encoded dehydrogenase and reductase activities.

Luesch H, Hoffmann D, Hevel JM, Becker JE, Golakoti T, Moore RE.

J Org Chem. 2003 Jan 10;68(1):83-91.

PMID:
12515465
[PubMed - indexed for MEDLINE]
13.

Isolation and structure determination of nostocyclopeptides A1 and A2 from the terrestrial cyanobacterium Nostoc sp. ATCC53789.

Golakoti T, Yoshida WY, Chaganty S, Moore RE.

J Nat Prod. 2001 Jan;64(1):54-9.

PMID:
11170666
[PubMed - indexed for MEDLINE]
14.

Three new cryptophycins from Nostoc sp. GSV 224.

Subbaraju GV, Golakoti T, Patterson GM, Moore RE.

J Nat Prod. 1997 Mar;60(3):302-5.

PMID:
9090872
[PubMed - indexed for MEDLINE]
15.

Discovery of cryptophycin-1 and BCN-183577: examples of strategies and problems in the detection of antitumor activity in mice.

Corbett TH, Valeriote FA, Demchik L, Lowichik N, Polin L, Panchapor C, Pugh S, White K, Kushner J, Rake J, Wentland M, Golakoti T, Hetzel C, Ogino J, Patterson G, Moore R.

Invest New Drugs. 1997;15(3):207-18. Review.

PMID:
9387043
[PubMed - indexed for MEDLINE]
16.

Treatment of human prostate tumors PC-3 and TSU-PR1 with standard and investigational agents in SCID mice.

Polin L, Valeriote F, White K, Panchapor C, Pugh S, Knight J, LoRusso P, Hussain M, Liversidge E, Peltier N, Golakoti T, Patterson G, Moore R, Corbett TH.

Invest New Drugs. 1997;15(2):99-108.

PMID:
9220288
[PubMed - indexed for MEDLINE]
17.

Preclinical anticancer activity of cryptophycin-8.

Corbett TH, Valeriote FA, Demchik L, Polin L, Panchapor C, Pugh S, White K, Knight J, Jones J, Jones L, LoRusso P, Foster B, Wiegand RA, Lisow L, Golakoti T, Heltzel CE, Ogino J, Patterson GM, Moore RE.

J Exp Ther Oncol. 1996 Mar;1(2):95-108.

PMID:
9414393
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk